AMELIE (Anchored Muscle cells for Incontinence) is a 5-year collaborative research project funded by the European Union Framework Programme (Horizon 2020). It involves the collaboration of 13 organisations across nine countries to develop and carry out research. The project is co-ordinated by UCL and led by Richard Day, Professor of Regenerative Medicine Technology at UCL.
Bowel Research UK leads on patient and public involvement for this project.
Faecal incontinence is a serious public health problem, affecting over 67 million people in Europe. AMELIE is primarily concerned with the effect of injury to the anal sphincter by childbirth, surgery or trauma. Many such patients are unsuitable for current surgical options. Our research aims to provide a new form of regenerative treatment.
For more information, visit the AMELIE website.
